QUEBEC CITY, March 16, 2016 /CNW Telbec/ – Opsens Inc. (“Opsens” or the “Company”) (TSXV: OPS) (OTCQX: OPSSF) today announces the 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the OptoWire II, an optical guidewire developed to measure Fractional Flow Reserve…